Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

Cantor Fitzgerald & Robbins Geller Rudman & Dowd LLP

3 shared events · Importance 3 · Last updated Aug 18, 2026

Importance
3
Shared Events
3
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
24
Regulatory
Cantor Fitzgerald: Analyst firm that published a negative note on the FDA briefing documents.
Robbins Geller Rudman & Dowd LLP: Law firm that announced the class action lawsuit.
Jul 27, 2026 · 305 articles
20
Regulatory
Cantor Fitzgerald: Cantor Fitzgerald downgraded ADMA Biologics stock from Overweight to Neutral following the Culper Research report.
Robbins Geller Rudman & Dowd LLP: Robbins Geller Rudman & Dowd LLP announces the class action lawsuit against ADMA Biologics and seeks lead plaintiff.
Jun 14, 2026 · 294 articles
15
Regulatory
Cantor Fitzgerald: Cantor Fitzgerald analyst Kristen Kluska published an investor note stating the FDA briefing documents paint an ugly picture and raise concerns about the integrity of data collection, a view cited in the complaint.
Robbins Geller Rudman & Dowd LLP: Plaintiff law firm announcing the Capricor class action and the September 28, 2026 lead plaintiff deadline.
Aug 10, 2026 · 267 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Cantor Fitzgerald and Robbins Geller Rudman & Dowd LLP interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.